At American Gene Technologies® we are very proud and fortunate to work with some of the best scientific and clinical advisors in their fields. As a team we continually push our research forward.
MANAGEMENT TEAM
Our experienced executive team is committed to finding innovative solutions for patients living with infectious diseases, cancer, and monogenic disorders.
Jeff Galvin
Founder and CEO
Jeff earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of...
Jeff Boyle, PhD
Chief Science Officer
Jeff has over 25 years of research, development, and technical expertise with a deep understanding of biotechnology. Dr. Boyle has held multiple executive roles in the biotech and...
Marcus A. Conant, MD
Chief Medical Officer
Marcus is a physician who treated thousands of HIV patients in the early 80s while running the inpatient dermatology service at the University of California San Francisco. Before anyone recognized...
Lola Liao, CPA
Director of HR & Admin
Lola is Director of Finance and Administration at American Gene Technologies®, where she oversees accounting and finance activities and reporting, including tax preparation, Maryland Innovation Investment...
Andrew Miller, CPA
VP of Finance
Andrew has more than 20 years of experience in accounting, finance, strategy, raising capital, and corporate governance in both private companies and non-profit organizations.
Jane Jing
Director of Business Unit
Jane joined American Gene Technologies® in October 2021 and leads the Diagnostic Business Unit. Jane oversees the daily operations of the Diagnostic Business Unit, including lab, billing and sales.
Drew Palin, MD
Chief Business Officer
Drew is a bold healthcare entrepreneur with rare expertise encompassing clinical medicine, information technology, and medical device. He is the founding CEO...
Kathy Fowler
Director of Marketing
Kathy spearheads American Gene Technologies® public relations and marketing strategy, building support for its clinical, business and development goals. She is a masterful storyteller...
BOARD OF DIRECTORS
Jeff Galvin
CEO and Founder
Jeff earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of…
Jason T. Thompson
Director
Jason combines legal experience and strategic vision in helping his clients structure, negotiate, and integrate corporate acquisitions. His training as a certified public accountant adds...
Aaron Galvin
Director
Aaron earned his BS and MS from the Massachusetts Institute of Technology (MIT), joining the MIT Lincoln Labs to pioneer innovations to radar as well as developing technologies ...
Qi Tang
Director
Qi has developed manufacturing and import/export businesses throughout China and the United States, and has invested several times throughout AGT™ growth.
Julia Brown
Director
Julia has served on the board of directors of nine drug development companies with a focus on governance and compensation. She currently serves on the board...
PROFESSIONAL ADVISORS
Tommy Thompson
Senior Advisor to the CEO
Tommy, former Secretary of the United States Department of Health and Human Services, worked fervently to modernize healthcare delivery as the former Governor of…
Robert R. Redfield, MD
Special Advisor to the CEO
Robert is well known for his decades of dedicated work in virology, immunology and clinical research. He has helped lead collaborative research into HIV/AIDS since the beginning of the epidemic...
DLA Piper provides AGT with corporate legal advice.
Foley & Lardner protects our innovative technologies and cures.
Ernst & Young serves as our independent public accountant.
